We build your
intellectual property

We are pleased to announce that our partner Koen Vanhalst has once again been recognised in the IAM Strategy 300: The World’s Leading IP Strategists 2026.

The IAM Strategy 300 identifies leading professionals who are recognised for their ability to develop and implement strategies that maximise the value of intellectual property.

On June 17, 2026, the European Parliament adopted Regulation (EU) 2026/1388 on plants obtained by New Genomic Techniques (NGTs), which entered into force on July 16, 2026.

Negotiations for this new EU Regulation began after a CJEU decision in 2018, which ruled that plants obtained through targeted mutagenesis (such as the CRISPR-Cas9 gene-editing technique) were captured by the Regulation on genetically modified organisms (GMOs) and all the strict requirements that entails, despite the fact that such NGT plants (cisgenesis and targeted mutagenesis) scientifically differ from traditional GMOs (transgenesis) in that they do not necessarily contain “foreign DNA”.

Anyone who still believes that artificial intelligence operates in a legal vacuum has probably spent the past two years somewhere without Wifi. The European AI Act is now very much with us and, since 2 August 2026, a number of its rules have become directly relevant to businesses that do not build AI systems, train foundation models or employ rooms full of data scientists. They simply use AI. In other words: almost everyone.